Min Wang

Dr. Min Wang


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
YQYa Qi
Ya Qi
MWMin Wang
Min Wang
QJQi Jiang
Qi Jiang
Mammalian poly A-binding proteins (PABPs) are highly conserved multifunctional RNA-binding proteins primarily involved in the regulation of mRNA translation and stability, of which PABPC1 is considered a central regulator of cytoplasmic mRNA homing and is involved in a wide range of physiological and pathological processes by regulating almost every aspect of RNA metabolism. Alterations in its expression and function disrupt intra-tissue homeostasis and contribute to the development of various tumors. There is increasing evidence that PABPC1 is aberrantly expressed in a variety of tumor tissues and cancers such as lung, gastric, breast, liver, and esophageal cancers, and PABPC1 might be used as a potential biomarker for tumor diagnosis, treatment, and clinical application in the future. In this paper, we review the abnormal expression, functional role, and molecular mechanism of PABPC1 in tumorigenesis and provide directions for further understanding the regulatory role of PABPC1 in tumor cells.

6 December 2018 in Medical Science Monitor
Verified
Journal Article
Closed access
PDF file
CSCong Shi
Cong Shi
MWMin Wang
Min Wang
BACKGROUND:Epithelial ovarian cancer (EOC) has a high mortality rate and is a common malignant tumor of women, seriously impairing health. Chemoresistance is one of the major causes of poor prognosis. Therefore, analyzing the molecular mechanism of p...

25 July 2022 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
SZSiyang Zhang
Siyang Zhang
HWHan Wang
Han Wang
JLJiao Liu
Jiao Liu
TTTao Tao
Tao Tao
ZZZhi Zeng
Zhi Zeng
MWMin Wang
Min Wang
Background: Effective treatment is needed for advanced, inoperable, or chemotherapy-resistant cervical cancer patients. Immunotherapy has become a new treatment modality for cervical cancer patients, and there is an urgent need to identify additional targets for cervical cancer immunotherapy. Methods: In this study the core gene, RGS1, which affects immune status and the FIGO stage of cervical cancer patients was identified by WGCNA analysis and differential analysis using TCGA database. 10 related genes interacting with RGS1 were identified using PPI network, and the functional and immune correlations were analyzed. Based on the expression of RGS1 and related genes, the consensus clustering method was used to divide CESC patients into two groups (group 1, high expression of RGS1; group 2, low expression of RGS1). Then, the functional enrichment analysis was used to search for the functional differences in differentially expressed genes (DEGs) between group 1 and group 2. Immune infiltration analysis was performed using ESTIMATE, CIBERSORT, and ssGSEA, and the differences in expression of immune checkpoint inhibitors (ICIs) targets were assessed between the two groups. We investigated the effect of RGS1 on the clinical relevance of CESC patients, and experimentally verified the differences in RGS1 expression between cervical cancer patient tissues and normal cervical tissues, the role of RGS1 in cell function, and the effect on tumor growth in tumor-bearing mice. Results: We found that RGS1 was associated with CD4, GNAI3, RGS2, GNAO1, GNAI2, RGS20, GNAZ, GNAI1, HLA-DRA and HLA-DRB1, especially CD4 and RGS2. Functional enrichment of DEGs was associated with T cell activation. Compared with group 2, group 1 had stronger immune infiltration and higher ICI target expression. RGS1 had higher expression in cervical cancer tissues than normal tissues, especially in HPV-E6 positive cancer tissues. In cervical cancer cell lines, knockdown of RGS1 can inhibited cell proliferation, migration, invasion, and tumor growth in nude mice and promoted apoptosis. Conclusions: RGS1, as an oncogenic gene of cervical cancer, affects the immune microenvironment of patients with cervical cancer and may be a target of immunotherapy.

30 April 2019 in BioScience Trends
Verified
Journal Article
Open access
PDF file
YGYan Gao
Yan Gao
CZChuanqi Zhang
Chuanqi Zhang
YLYisi Liu
Yisi Liu
MWMin Wang
Min Wang
Circular RNA (circRNA) is a class of endogenous non-coding RNAs that are closely related to the pathogenesis of many human diseases, particularly cancer. However, the characterization of circRNAs in high-grade serous ovarian cancer (HGSOC) remains unknown. This study aimed to investigate the expression profile of circRNAs in HGSOC. Expression profiles of circRNAs differential expression based on circRNAs High-throughput sequencing were identified in 3 HGSOC specimens and 3 normal ovarian tissues. A total of 710 differentially expressed circRNAs were found (354 expressions up-regulated and 356 expressions down-regulated). CircRNA sequencing data were verified by qRT-PCR in HGSOC tissue and benign ovarian lesions. Differential expression of 7 circRNAs (circRNA385, circRNA2058, circRNA3336, circRNA2606, circRNA1656, circRNA1312 and circRNA7474) in HGSOC tissue was confirmed by qRT-PCR. Among them, circRNA1656 showed the highest fold change. qRT-PCR was used to verify the expression of circRNA1656 in ovarian cancer cell lines. In order to analyze the relationship between circRNA1656 expression and clinical pathological biological characteristics of HGSOC, qRT-PCR was used to verify the expression of circRNA1656 in 60 HGSOC tissues compared with 60 benign ovarian lesions. The expression of circRNA1656 was down-regulated in HGSOC tissues and ovarian cancer cell lines, and correlated with the FIGO stage of HGSOC. circRNA1656 has the potential to serve as a novel tumor marker for HGSOC.

10 March 2020 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
PDF file
CPCheng Pei
Cheng Pei
HWHan Wang
Han Wang
CSCong Shi
Cong Shi
CZChuanqi Zhang
Chuanqi Zhang
MWMin Wang
Min Wang
Background: CircRNA plays an important role in the development of tumors, but its mechanism of action in ovarian cancer is still unclear.Methods: The expression level of hsa_circ_0013958 in 45 pairs of ovarian cancer tissues and cells was quantified by qRT‐PCR, further revealing whether it is related to clinicopathological features and diagnostic value. Next, the effects of hsa_circ_0013958 on the proliferation, migration, invasion, and apoptosis of A2780 and OVCAR‐3 cells were detected by CCK‐8 assay, Transwell assay, and flow cytometry, respectively. Last, the expression levels of epithelial‐mesenchymal transition‐related proteins (E‐cadherin and Vimentin) and apoptosis‐related proteins (Bcl‐2 and Bax) were detected by Western blotting.Results: Hsa_circ_0013958 was highly expressed in ovarian cancer tissues and cells, and its expression was closely related to patient FIGO stage and lymph node metastasis. Further, in vitro studies showed that knockdown of hsa_circ_0013958 suppressed proliferation, migration, and invasion of ovarian cancer cells but elevated the cell apoptotic rate. The expression levels of both epithelial‐mesenchymal transition‐related proteins and apoptosis‐related proteins were also changed.Conclusions: Hsa_circ_0013958 may contribute to the development of ovarian cancer by affecting epithelial‐mesenchymal transition and apoptotic signaling pathways.

2 May 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
TTTao Tao
Tao Tao
PZPing Zhang
Ping Zhang
ZZZhi Zeng
Zhi Zeng
MWMin Wang
Min Wang